ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 9 FEBRUARY 2023 AT 9:45 A.M. EET Change in Enento Group's Executive Management Team Eleonor Öhlander, Enento Group's Director of HR and member of
ENENTO GROUP PLC, STOCK EXCHANGE RELEASE ON 19 DECEMBER 2022 AT 6.00 P.M. EET Enento Group Plc: Shareholders' Nomination Board's proposal to Annual General Meeting 2023 Enento Group Plc's
we ve beenen buildingg ththis countryry for 119 y yea, and d choose onene of the thouousands of n new ford trts but we r re just getting ststarted. and d choose onene of the thouousands of n new ford trts (vo) whwhen you livive with mododero severe c crohn s s disease or ulcererative colilitis, youry can n be full ofof remindersrs but we r re just getting ststarted. ofof your condndition. nevevr knowowing. alwayays wonderin. you weweren t mamade for uc r crohohn s, bubut gut focucused entyvivio. entyvio o works at t the site oe proboblem to blolock cecertain inflflammation-c-cag cells fromom entering g the g. infusionon and serioious allerc reacactions can n happen during or after treatment. entyvio mamay increase risk of infection which can be serious. althoughgh unlikely,y, a riskf pml, a a rare, sererious, potentialllly fatal brbrain ininfection cacannot be rurule. tell youour doctor i if you havn infefection, expxperience frequent i infections,s, or he flu-likeke symptoms s or sore
ENENTO GROUP PLC, INVESTOR NEWS ON 12 DECEMBER 2022 AT 11.30 A.M. EET IT incident in Sweden resolved The IT incident that affected some of Enento's services in Sweden is now resolved and all
ENENTO GROUP PLC, INVESTOR NEWS ON 7 DECEMBER 2022 AT 12.00 A.M. EET In Enento Group's English investor news regarding the IT incident affecting some of Enento's services in Sweden, published on 5